Participate in polls relating to real-time continuous glucose monitoring and see how your answers relate to your colleagues.

Polling Question:

The DIaMonD (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) trial found that:
CGM significantly decreased diabetes distress
CGM significantly enhanced hypoglycemic confidence
CGM significantly improved both diabetes distress and hypoglycemic confidence
CGM significantly improved patients' well-being
CGM significantly improved patients' health status

Submit
©2020 CogniMed Inc. All rights reserved.